The odds ratios for lung adenocarcinoma with the EGFR Q787Q polymorphismwere 1.44 (95% CI=1.13-1.85; p=0.004), 1.75 (95% CI=1.21-2.51; p=0.003), and 1.27 (95% CI=0.93-1.73; p=0.14) for all patients, EGFR wild-type and EGFR-mutated lung adenocarcinoma, respectively (Figure 1). This evidence concerns the gene EGFR and lung adenocarcinoma.